UCNQX | VIGIX | UCNQX / VIGIX | |
Total Expense Ratio | 1.45 | 0.04 | 3,625% |
Annual Report Gross Expense Ratio | 1.61 | 0.04 | 4,025% |
Fund Existence | 5 years | 27 years | - |
Gain YTD | 16.065 | 16.200 | 99% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 2500 | 5000000 | 0% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 8.08B | 328B | 2% |
Annual Yield % from dividends | 0.00 | 0.43 | - |
Returns for 1 year | 19.79 | 24.24 | 82% |
Returns for 3 years | 98.48 | 117.87 | 84% |
Returns for 5 years | 86.95 | 114.12 | 76% |
Returns for 10 years | N/A | 386.73 | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
RAGHX | 26.03 | N/A | N/A |
Virtus KAR Health Sciences A | |||
GCTAX | 51.60 | N/A | N/A |
Goldman Sachs US Tax-Managed Eq A | |||
INDIX | 17.59 | N/A | N/A |
Kotak India Equity Fund Class I | |||
ABCIX | 23.58 | -0.04 | -0.17% |
American Beacon The London Co Inc Eq R5 | |||
FBONX | 38.40 | -0.16 | -0.41% |
American Funds American Balanced 529-F-3 |